Portfolio (Quarterly)
Guide ↗
Vivo Capital, LLC
· CIK 0001674712| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | LBRX | LB Pharmaceuticals Inc | Healthcare | 800,000.0 | $19.7M | 1.64% | NEW | — | $24.66 | +13.4% |
| 22 | MANE | Veradermics Inc | Healthcare | 300,000.0 | $18.9M | 1.57% | NEW | — | $63.15 | +56.9% |
| 23 | CAMP | CAMP4 Therapeutics Inc | Healthcare | 4,246,568.0 | $18.7M | 1.56% | NEW | — | $4.41 | -3.4% |
| 24 | MLTX | Moonlake Immunotherapeutics | Healthcare | 1,000,000.0 | $18.6M | 1.55% | NEW | — | $18.64 | +0.2% |
| 25 | DSGN | Design Therapeutics Inc | Healthcare | 1,612,903.0 | $17.2M | 1.43% | NEW | — | $10.64 | +4.9% |
| 26 | COGT | Cogent Biosciences Inc | Healthcare | 422,300.0 | $16.3M | 1.35% | NEW | — | $38.49 | -11.1% |
| 27 | GERN | Geron Corp | Healthcare | 8,671,797.0 | $12.9M | 1.07% | NEW | — | $1.49 | -14.4% |
| 28 | UNCY | Unicycive Therapeutics | Healthcare | 1,789,916.0 | $11.8M | 0.98% | NEW | — | $6.58 | +6.0% |
| 29 | ANTX | AN2 Therapeutics Inc | Healthcare | 3,153,640.0 | $10.8M | 0.90% | NEW | — | $3.42 | +36.8% |
| 30 | OLMA | Olema Pharmaceuticals Inc | Healthcare | 671,843.0 | $10.0M | 0.83% | NEW | — | $14.91 | -13.3% |
| 31 | — | Soleno Therapeutics Inc | — | 294,909.0 | $9.9M | 0.82% | NEW | — | $33.48 | — |
| 32 | — | Eupraxia Pharmaceuticals Inc | — | 1,350,000.0 | $9.8M | 0.81% | NEW | — | $7.24 | — |
| 33 | — | Onkure Therapeutics Inc | — | 1,927,710.0 | $8.0M | 0.66% | NEW | — | $4.14 | — |
| 34 | — | Surrozen Inc | — | 260,000.0 | $7.6M | 0.63% | NEW | — | $29.13 | — |
| 35 | ALXO | ALX Oncology Holdings Inc | Healthcare | 3,184,713.0 | $6.4M | 0.53% | NEW | — | $2.01 | -4.0% |
| 36 | — | Monopar Therapeutics Inc | — | 90,500.0 | $5.0M | 0.41% | NEW | — | $54.79 | — |
| 37 | MSLE | Satellos Bioscience Inc | Healthcare | 813,666.0 | $4.6M | 0.38% | NEW | — | $5.63 | +25.3% |
| 38 | PEPG | Pepgen Inc | Healthcare | 2,325,000.0 | $4.1M | 0.34% | NEW | — | $1.77 | -14.4% |
| 39 | SERA | Sera Prognostics Inc | Healthcare | 1,650,440.0 | $3.4M | 0.28% | NEW | — | $2.03 | +10.3% |
| 40 | — | Tenax Therapeutics Inc | — | 208,333.0 | $3.3M | 0.28% | NEW | — | $15.99 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%